New COVID-19 vaccines designed to target the “Kraken” subvariant of Omicron have reached pharmacy shelves in Australia, as the country deals with increasing case numbers and the prospect of another wave of the pandemic.
The XBB 1.5 shots, recently approved by the Therapeutic Goods Administration (TGA), can serve as both a primary immunisation dose and a booster.